Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 4/20 | 0.41 |
| ▸ | SLC22A12 | Q96S37 | 4/20 | 0.41 |
| ▸ | TTR | P02766 | 2/20 | 0.41 |
| ▸ | ALB | P02768 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.40 |
| ▸ | AKR1C1 | Q04828 | 3/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.38 |
| ▸ | AKR1C4 | P17516 | 2/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27342130 | 0.82 | XDH (0.50) | XDHSLC22A12TTRALBMEN1 | |
| SCHEMBL4852671 | 0.81 | XDH (0.38) | XDHSLC22A12KDM4EHSD17B10GPR35 | |
| SCHEMBL546515 | 0.79 | HMGB1 (0.53) | XDHSLC22A12TTRALBMEN1 | |
| SCHEMBL11559081 | 0.79 | CSNK2A1 (0.44) | AKR1C2AKR1C1KDM4EHSD17B10 | |
| SCHEMBL8658135 | 0.79 | KDM4E (0.41) | XDHSLC22A12TTRALBMEN1 | |
| SCHEMBL3679283 | 0.79 | TTR (0.54) | SLC22A12TTRALBMEN1KMT2A | |
| SCHEMBL11727517 | 0.78 | VCAM1 (0.53) | MEN1KMT2AGPR35 | |
| SCHEMBL4849457 | 0.75 | GPR35 (0.42) | XDHSLC22A12TTRALBMEN1 | |
| SCHEMBL31596359 | 0.75 | PKM (0.49) | SLC22A12TTRALBMEN1KMT2A | |
| SCHEMBL7196160 | 0.74 | XDH (0.46) | XDHSLC22A12ALBKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1871844-B1 | BUBBLE COMPOSITION WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2014-08-27 | — | — | EP | disclosed |
| EP-1871844-A2 | NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C Technologies LLC (US) | 2008-01-02 | — | — | EP | disclosed |
| WO-2007008389-A2 | USE OF COLOR CHANGING INDICATORS IN CONSUMER PRODUCTS | C2C TECHNOLOGIES LLC (US) | 2007-01-18 | — | — | WO | disclosed |
| US-20070010400-A1 | Use of color changing indicators in consumer products | C2C TECHNOLOGIES, LLC | 2007-01-11 | — | — | US | disclosed |
| US-20060257439-A1 | Cleansing compositions with color changing indicator | CRAYOLA LLC | 2006-11-16 | — | — | US | disclosed |
| US-20060236470-A1 | Novelty compositions with color changing indicator | CRAYOLA LLC | 2006-10-26 | — | — | US | disclosed |
| WO-2006105193-A2 | PERSONAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105261-A1 | CLEANSING COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105260-A1 | ORAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006105191-A2 | NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| US-20060222601-A1 | Oral care compositions with color changing indicator | C2C TECHNOLOGIES, LLC | 2006-10-05 | — | — | US | disclosed |
| US-20060222675-A1 | Personal care compositions with color changing indicator | C2C TECHNOLOGIES, LLC | 2006-10-05 | — | — | US | disclosed |
| US-5080832-A | 4-aminobenzoic acid and dinitro- or decyanobenzoic acid compounds; coherent radiation | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1992-01-14 | — | — | US | disclosed |
| US-4992214-A | Crystalline; with intermolecular hydrogen bonding | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1991-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060222675-A1 | Personal care compositions with color changing indicator | CUTA, POLR1C, TYR | XDH 1532/4885SLC22A12 2486/4885TTR 927/4885 |
| US-20060257439-A1 | Cleansing compositions with color changing indicator | WASHC5, WASHC4, FHIT | XDH 2515/4885SLC22A12 438/4885TTR 121/4885 |
| US-20060222601-A1 | Oral care compositions with color changing indicator | CA9, CA7, TAS2R7 | XDH 1738/4885SLC22A12 714/4885TTR 280/4885 |
| US-20070010400-A1 | Use of color changing indicators in consumer products | NQO2, CA4, CA7 | XDH 1321/4885SLC22A12 438/4885TTR 1675/4885 |
| US-20060236470-A1 | Novelty compositions with color changing indicator | MITF, CRABP2, SHH | XDH 1338/4885SLC22A12 2584/4885TTR 2182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.